Showing results (141-150 of 258) with videos related to

Sort By:
Pageof 26
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 12, 2016
Syntheses of Platinum-Sulindac Complexes and Their Nanoparticles as Targeted Anticancer DrugsJih Ru Hwu, Shwu-Chen Tsay, Kao Shu Chuang, et al.
Cancer Chemotherapy and Pharmacology|February 18, 2014
A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancerYee Chao, Jan-Sing Hsieh, Hsien-Tang Yeh, et al.
Bioconjugate Chemistry|September 24, 2008
Modularly assembled magnetite nanoparticles enhance in vivo targeting for magnetic resonance cancer imagingPing-Ching Wu, Chia-Hao Su, Fong-Yu Cheng, et al.
Targeted Oncology|June 17, 2023
Efficacy and Tolerability of Ramucirumab Plus Erlotinib in Taiwanese Patients with Untreated, Epidermal Growth Factor Receptor-Mutated, Stage IV Non-small Cell Lung Cancer in the RELAY StudyChao-Hua Chiu, Meng-Chih Lin, Yu-Feng Wei, et al.
American Journal of Epidemiology|August 13, 2009
Interactive effect of cigarette smoking with human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) polymorphisms on the risk of lung cancer: a case-control study in TaiwanChin-Hao Chang, Chin-Fu Hsiao, Gee-Chen Chang, et al.
Urology|July 26, 2020
Clinical Frailty Scale in Predicting Postoperative Outcomes in Older Patients Undergoing Curative Surgery for Urologic Malignancies: A Prospective Observational Cohort StudyChien-Yao Sun, Chien-Cheng Huang, Yuh-Shyan Tsai, et al.
Plos One|June 29, 2016
Epidermal Growth Factor Receptor Mutation and Anaplastic Lymphoma Kinase Gene Fusion: Detection in Malignant Pleural Effusion by RNA or PNA AnalysisYi-Lin Chen, Chung-Ta Lee, Cheng-Chan Lu, et al.
Thoracic Cancer|November 20, 2021
Improved survival in patients with unresectable stage III EGFR-mutant adenocarcinoma with upfront EGFR-tyrosine kinase inhibitorsSheng-Yuan Wang, Ching-Han Lai, Chian-Wei Chen, et al.
Cancer Medicine|August 22, 2019
Real-world outcomes of NSCLC patients receiving tissue or circulating tumor DNA-guided osimertinib treatmentPo-Lan Su, Szu-Chun Yang, Yi-Lin Chen, et al.
British Journal of Cancer|June 21, 2019
A phase 1, open-label, dose-escalation trial of oral TSR-011 in patients with advanced solid tumours and lymphomasChia-Chi Lin, Hendrik-Tobias Arkenau, Sharon Lu, et al.
Pageof 26